Wednesday, 15 Jul 2020

Bangla Version

Gonoshasthaya asks BSMMU to suspend performance trial of test kit

No icon Pharmaceuticals

Health Desk- 04 May 2020: Gonoshasthaya Kendra has asked the Bangabandhu Sheikh Mujib Medical University to suspend the performance trial of the coronavirus antigen kit after detection of discrepancy in the collection of saliva.

"The monitoring team for the performance trial identified that the presence of thick cough causes negative results in a number of samples. So, we have sought temporary suspension of the trial," said Dr Mohib Ullah Khondoker, coordinator of Gonoshasthaya's Covid-19 Rapid Dot Blot Project.

He told media that clear saliva is necessary for testing antigen, but the monitoring team that is comprised of scientists of BSMMU and Gonoshasthaya Kendra identified the problem in the sample collection procedure.

"We have written to the BSMMU authorities on June 2 that we will fix the sample collection procedure in two to three days and then they can restart the trial again," Mohib Ullah said on Wednesday .

Gonoshasthaya Kendra Founder and Trustee Dr Zafrullah Chowdhury has repeatedly demanded that the authorities go for emergency authorisation of the antibody kits as the infection rate is increasing every day.

The antibody kit, which is low-cost and can give result in 10 minutes, could be used for large-scale testing and isolation of the infected people -- a way that could prevent the spread of the virus, he said recently.

In its own trial, Gonoshasthaya found the tests to be more than 90 percent accuracy.